CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Attend An Event
State of the Science Summit
Regional Seminar Series
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
<< View More Conferences
AUA Annual Meeting
Oncology Conference Multimedia
View more videos >>
Dr. Shore on a Long-Term Safety Analysis of the COU-AA-302 Study
Dr. Kapoor Discusses the Inclusion of Radium-223 in AUA Guidelines for CRPC
Dr. Evans Discusses the Subgroup Analysis Results of the PREVAIL Study
Oncology Conference Articles
PSA Growth Rate May Help Identify Aggressive Prostate Cancer Early
Analysis of trends in prostate-specific antigen (PSA) dynamics suggested that PSA growth rates, as well as the amount of PSA-level increase due specifically to cancer, might offer a means of distinguishing aggressive, potentially fatal prostate cancer from clinically inconsequential tumors.
Intermittent Degarelix Effective With Less Metabolic Syndrome Than Hormone Agonists, Studies Suggest
Men given the GnRH antagonist degarelix because their PSA level rose after primary therapy fared at least as well on an intermittent medication schedule as on a continuous schedule
Cell-Cycle Gene Test Shows Early Promise in Clear Cell RCC
A cell-cycle gene array test demonstrated independent value for predicting metastatic progression after surgery for organ-confined renal cell carcinoma (RCC) of clear cell histology, a retrospective study of patient data showed.
ED Therapy May Preserve Function, Penile Length After Prostatectomy
Daily treatment with the PDE-5 inhibitor tadalafil (Cialis) led to a significant decrease in loss of penile length among men who had undergone bilateral nerve-sparing radical prostatectomy.
Testicular Self-Examination Cost-Effective Compared with Missed Advanced Cancer
Testicular self-examination remains highly cost-effective despite a negative recommendation from the United States Preventive Services Task Force (USPSTF), a cost-utility analysis suggested.
In Dog Study, Prostate Cancer Found With a Whiff and a Woof
When it comes to detecting prostate cancer accurately and noninvasively, dogs may be ahead by a nose.
Social Media Vital in Marketing Large Urology Practices
In the age of social media, simply having a website isn't enough. To keep existing patients and attract new ones, large urology group practices need to build websites that are connected to social media outlets at every turn, said Peter M. Knapp, Jr, MD.
Physical Activity Linked to Lower Risk of Death from Bladder Cancer
Self-reported physical activity significantly improved the odds that a person would not die of bladder cancer, a review of a national health information database showed.
Active Surveillance Is No Threat to Prostate Cancer Cure-So Far
Prostate cancer patients who chose active surveillance did not compromise their chances of a cure by waiting before they underwent radical prostatectomy, data from a Swedish registry showed.
FDA Approval in HCC, Breakthrough Designation in MCL, and More
Dabrafenib/Trametinib Combo Induces High Responses in BRAF V600E-Mutant Biliary Tract Cancer
Treatment Goals in Refractory mCRC
FDA Approves Third Trastuzumab Biosimilar
Olaratumab Falls Short in Phase III Soft Tissue Sarcoma Trial
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.